This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Ariceum Therapeutics Gmbh. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Innovations of Anne Petit in Radiopharmaceuticals
Introduction
Anne Petit is an accomplished inventor based in Dreux, France. She has made significant contributions to the field of radiopharmaceuticals, holding a total of 2 patents. Her work focuses on the development of somatostatin analogue compositions, which have important applications in both diagnostic and therapeutic settings.
Latest Patents
Anne Petit's latest patents include a composition containing a somatostatin analogue for radiopharmaceutical use. This invention specifically relates to a receptor-selective somatostatin peptide antagonist, which is designed for diagnostic or therapeutic applications. The innovative nature of her work lies in the potential of these compositions to enhance the effectiveness of radiopharmaceuticals.
Career Highlights
Throughout her career, Anne Petit has demonstrated a strong commitment to advancing medical science through her inventions. She is currently associated with Ariceum Therapeutics GmbH, where she continues to explore new avenues in the field of radiopharmaceuticals. Her expertise and innovative spirit have positioned her as a key figure in her area of research.
Collaborations
Anne Petit collaborates with notable colleagues, including Joel Richard and Anne-Claire Le Meur. These partnerships enhance her research efforts and contribute to the development of groundbreaking technologies in the medical field.
Conclusion
Anne Petit is a pioneering inventor whose work in radiopharmaceuticals is making a significant impact. Her contributions, particularly in the area of somatostatin analogue compositions, are paving the way for advancements in medical diagnostics and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile